Amgen has welcomed Health Minister Mark Butler's confirmation that the PBS listing of osteoporosis therapy EVENITY (romosozumab) has been expanded to a first-line setting for people who have had one fracture and are at very high risk of another. …
Amgen welcomes expanded listing of biologic osteoporosis therapy
November 21, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
Is New Zealand leading Australia on AI in medicines evaluation and assessment
August 18, 2025 - - Latest News -
Lilly launches new initiative with Monash University to improve gaps in obesity management
August 18, 2025 - - Latest News -
Should we keep these processes separate until the minister has determined the outcome?
August 18, 2025 - - Latest News -
Novartis unveils new solution to simplify HCP access to private prescriptions
August 18, 2025 - - Latest News -
A journey to complexity - the PBAC’s decade-long language shift on pricing and access
August 18, 2025 - - Latest News -
Novo Nordisk launches global-first Marie Krogh Young Women in Science Prize in Australia
August 18, 2025 - - Latest News -
BeiGene launches its new name and brand identity in Australia and New Zealand
August 18, 2025 - - Latest News